Sandell Asset Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Sandell Asset Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-748,730	Closed	-$12.7M	–	53
2014 Q4	$12.7M	Buy	+748,730	New	+$10.5M	1.27%	31

Sandell Asset Management's AVNR Position: Q1 2015 in Review

Sandell Asset Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 748,730 shares — an estimated $12.7M sold.

Sandell Asset Management first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $12.7M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Sandell Asset Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Sandell Asset Management sold 748,730 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $12.7M.
Sandell Asset Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Sandell Asset Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $12.7M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Sandell Asset Management's 13F filing for Q1 2015, filed 15 May 2015.